SWITCH SWEDEHEART trial shows prasugrel matches ticagrelor with less bleeding
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary…
Antiplatelet medications linked to worse outcomes in people hospitalized with a brain bleed
Analysis of hospital registry data found that people who were hospitalized due to bleeding in the brain and…
Prasugrel shows advantage over ticagrelor in diabetic patients after stent placement
One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors-ticagrelor or prasugrel-in people with Type…